Navigation Links
Ferguson-Frazier suction tube # 2
1 x 2 teeth, cross serrated 5 mm 60 degree angled platform. Round knurled handle with polished finish.
Narrow 4 mm long smooth platform. Serrated handle with polished finish.
1 mm smooth 45 degrees angled jaws. Cross action serrated handle with polished finish.
Oval solid 16 mm wide lower plate. Open upper plate with inside dimensions 12 mm x 14 mm. Serrated handle with locking thumb screw and polished finish.
Medicine Products:
(Date:10/7/2008)... Licensed Chiropractor Dr. Richard A. ... Newburgh, NY (Vocus) October 7, 20...one of the most stressful times in its history. H...ng costs of everything from phone bills to electri...creased stress. And with growing stress levels co...
(Date:10/7/2008)... Mickie Bellah,s Luminescence Series p...International Fine Art Gallery in the Chelsea Dist...Austin, TX (PRWEB) October 7, 2008 -- Austin Artis...ning of her Luminescence Series paintings at Amste... Chelsea District of New York City,October 10, 200...
(Date:10/6/2008)...s sold not helping fight against childhood obesity...(HealthDay News) -- Three-quarters of middle schoo...drinks are sold, a new study finds. , The resea...n most middle schools, and "that those vending mac...aid study author Amy Virus, a registered dietitian...
(Date:10/6/2008)..., Oct. 6 /PRNewswire-FirstCall/ -- Volcano Corpora..., manufacturing and sales of,products for the diag...ery,disease, today announced the relocation of its... Rancho Cordova to San Diego. The new corporate,he... San Diego and now,houses corporate executives, ma...
Breaking Medicine News(10 mins):Health News:Prescriptions for Stress 2Health News:Prescriptions for Stress 3Health News:Vending Machines Found in Most Middle Schools 2Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 2Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 3Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 4
... Respiratory and Critical Care Medicine says that ... in the blood could// help detect abnormal lesions...arker of inflammation and measuring the blood leve...ople at risk for developing lesions that could cau...
...nd after the health authorities promised to pay at...ding their safety and working hours//. As word sp... of patients poured into the hospitals. Long queue...ospitals. 'It could not have come at a better tim...
...ions of the oral cavity can be effectively treated...archers from the University at Buffalo's School of...y employed in cancer treatment. PDT is currently e...arcoma, breast cancer (spread to the chest wall) a...
...rd flu, it has been proposed to construct military...ovide the best help in the avian influenza fight. ...ished in the internationally acclaimed Nature jour...hrough co-ordination between such international la...
Other Medicine News:Health News:Infections Of The Oral Cavity Can Be Treated By Photodynamic Therapy 2
(Date:10/7/2008)...re-FirstCall/ - Burcon NutraScience,Corporation (T...,Supertein(TM) canola protein isolates are GRAS (G...e in a variety of food and beverage,applications. ...an,independent evaluation by a panel of qualified ...nutritional sciences, food allergies and pediatric...
(Date:10/7/2008)...wire-FirstCall/ -- CEL-SCI Corporation,(NYSE: CVM...rial Transfer,Agreement (MTA) with the National In... laboratory of Dr. Francesco M. Marincola, M.D., t...e tumor microenvironment,caused by CEL-SCI,s cance...e Infectious Disease and Immunogentics Section, De...
(Date:10/7/2008)... /- A study published in the,scientif...lf-renewal,reported that InVitria,s ( http://www....albumin) was an effective replacement to bovine se...tled, "The ground state of embryonic stem cell,sel...tim as a recombinant,albumin in place of animal-de...
(Date:10/7/2008)...RNewswire/ -- Taligen Therapeutics Inc.,today anno...s pipeline,candidates were presented at the XXII I...land. The data highlighted the candidates, efficac...diseases., "These highlighted presentations, as w...onference, reveal the deep expertise and expanding...
Breaking Medicine Technology:Burcon announces GRAS status for Puratein(R) & Supertein(TM) 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 3CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity 1443 1NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity 1443 2Home Care Agencies Responding to Patients Needs Still Have Room for Improvement 1441 1Home Care Agencies Responding to Patients Needs Still Have Room for Improvement 1441 2First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 1First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 2First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 3First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 4First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 5First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 6First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 7First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 8Directors Forum 3A PEPFAR and the Global AIDS Response 286 1Directors Forum 3A PEPFAR and the Global AIDS Response 286 2
...NA NIGUEL, Calif.--(BUSINESS WIRE)--Apr 26, 2007 -...ed today the publication*,in the April 18, 2007 is...archers at the University of Colorado and National...that the Company,s first,orally available catalyti...ction in an animal model of Parkinson,s disease ("...
...p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: left; ta... 0in 0in 0pt; tab-stops: list .5in; mso-list: l1 l...FAMILY: ,News Gothic MT,; mso-bidi-font-weight: bo...tic benefits of adding,Diovan to conventional ther...-stops: list .5in; mso-list: l1 level1 lfo2">, <sp...
Other Medicine Technology:Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 2Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 4Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 5Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 6Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 7Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 8Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 9Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 10Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 11Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 12